Advanced Cell Technology, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 72   

Articles published

ACTC 0.0580 -0.0060 (-9.38%)
price chart
Advanced Cell Technology: A Key Patent Critique (Part II)
The focus on credibility is very positive for the future of the company and as a potential investor, I applaud the effort. It truly is an inflection point in the management of the company, as I stated in my prior article, Advanced Cell Technology: A ...
Related articles »  
Advanced Cell Technology to Host Conference Call to Provide a Corporate Update
Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today that it filed its annual report on Form 10-K for the year ended December 31, 2013.
Related articles »  
Advanced Cell Technology On The Doorstep
Advanced Cell Technology (OTCQB:ACTC) filed their annual 10-K report on Wednesday, after some delay. This massive ... The document provides critical information on the company's finances and the status of their various programs. ACT also hosted a ...
Watch List - Tranzbyte Corp (OTCMKTS:ERBB), Advanced Cell Technology, Inc ...
Advanced Cell Technology, Inc (OTCMKTS:ACTC) recently declared that it filed its annual report on Form 10-K for the year ended December 31, 2013.
Related articles »  
Advanced Cell Technology: A Key Patent Critique
Advanced Cell Technology's patent claims vs. the scientific method used in their AMD trial appear contradictory. This is a follow up to my prior article: ... Advanced Cell Technology (OTCQB:ACTC) filed their 10-K and had a conference call to discuss ...
Morning Alert - Tranzbyte Corp (OTCMKTS:ERBB), Advanced Cell Technology ...
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) declared that it filed its annual report on Form 10-K for the year finished December 31, 2013.
BioTime, Inc. (BTX) news: BioTime Joins Advanced Cell Technology In The AMD ...
"Advanced Cell Technology: A Balanced Perspective Or Risk And Reward" - This article summarized the legacy issues involving Advanced Cell Technology and future potential of the company. Prior management left the company at the end of 2013, and the ...
OTC Market's Active Runners - Tranzbyte Corp (OTCMKTS:ERBB), Advanced ...
Advanced Cell Technology, Inc (OTCMKTS:ACTC) was at $0.0584, showing a -8.75% decrease. Around 17.30 million shares have been traded, versus an-average trading volume of 12.52 million shares.
Hot Stock's Alert � Advanced Cell Technology, Inc. (ACTC), Chromadex Corp ...
Birmingham, West Midlands - - April 22, 2014� (TechSonian) �Advanced Cell Technology, Inc. (ACTC) posted that it filed its annual report on Form 10-K for the year ended December 31, 2013.
Related articles »  
Stocks Buzz - Advanced Cell Technology, Inc. (OTCMKTS:ACTC), SK3 Group ...
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) increased 1.26% at the price of $0.0645 recently on a traded volume of 4.31 million shares, in comparison to 12.64 million shares of average trading volume.
Related articles »